Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
A private biopharmaceutical company .
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Belenos Biosciences is a company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Turnstone Biologics is a privately-held clinical stage biotech company.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 19 different industry categories.
Among tracked funding rounds, Erasca received $632.5M in a Post-IPO Equity round. OrbiMed's total known invested capital is $24.3B.
OrbiMed's average investment size is $109.6M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include ReCode Therapeutics, Synlogic, ACELYRIN, XinThera, Neurogastrx. These companies were founded in 2020 or later.